Novartis research head Bradner outlines a recalibrated drug engine 

Tuesday, November 20, 2018 - 17:20 in Psychology & Sociology

A portfolio overhaul comes as the research organization homes in on the toughest drug targets

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net